Resistance to Dasatinib Is Associated With the Activation of Akt in Oral Squamous Cell Carcinoma
Translational Research in Oral Oncology
doi 10.1177/2057178x17702920
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
SAGE Publications